Bashraheel, Mohammed K.
Eerlings, Sarah A.
De Wolf, Andre M.
Neyrinck, Arne
Van de Velde, Marc
Vandenbroucke, Geert
Carette, Rik
Feldman, Jeffrey
Hendrickx, Jan F. A. http://orcid.org/0000-0002-1360-9662
Article History
Received: 11 November 2021
Accepted: 27 December 2021
First Online: 28 January 2022
Declarations
:
: Jan Hendrickx has received lecture support, travel reimbursements, equipment loans, consulting fees and/or meeting organizational support from a number of companies involved with inhaled agent delivery (alphabetically): AbbVie, Acertys, Air Liquide, Allied Healthcare, Armstrong Medical, Baxter, Dräger, GE, Hospithera, Heinen und Löwenstein, Intersurgical, Maquet, MDMS, MEDEC, Micropore, Molecular, NWS, Philips, Quantum Medical. The other authors declare that they have no conflict of interest. None of the authors has been involved with the development of the Memsorb or financially rewarded in any way by DMF Medical, Halifax, Canada.